Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation.

Liu D, Hou J, Hu X, Wang X, Xiao Y, Mou Y, De Leon H.

Circ Res. 2006 Mar 3;98(4):480-9.

2.

Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.

Liang KW, Yin SC, Ting CT, Lin SJ, Hsueh CM, Chen CY, Hsu SL.

Eur J Pharmacol. 2008 Aug 20;590(1-3):343-54. doi: 10.1016/j.ejphar.2008.06.034.

PMID:
18590725
3.

Diversity and specificity of actions of Slit2 proteolytic fragments in axon guidance.

Nguyen Ba-Charvet KT, Brose K, Ma L, Wang KH, Marillat V, Sotelo C, Tessier-Lavigne M, Chédotal A.

J Neurosci. 2001 Jun 15;21(12):4281-9.

4.

Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.

Sakata Y, Xiang F, Chen Z, Kiriyama Y, Kamei CN, Simon DI, Chin MT.

Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2069-74.

5.

17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level.

Kappert K, Caglayan E, Huntgeburth M, Bäumer AT, Sparwel J, Uebel M, Rosenkranz S.

Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H538-46.

6.

Nerve cell signposts in the blood vessel roadmap.

Adams RH.

Circ Res. 2006 Mar 3;98(4):440-2. No abstract available.

7.

Potential anti-angiogenic role of Slit2 in corneal neovascularization.

Han X, Zhang MC.

Exp Eye Res. 2010 Jun;90(6):742-9. doi: 10.1016/j.exer.2010.03.007.

PMID:
20298689
8.

Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration.

Fu M, Zhang J, Tseng YH, Cui T, Zhu X, Xiao Y, Mou Y, De Leon H, Chang MM, Hamamori Y, Kahn CR, Chen YE.

Circulation. 2005 Mar 1;111(8):1071-7.

9.
10.

ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration.

Shimizu H, Hirose Y, Nishijima F, Tsubakihara Y, Miyazaki H.

Am J Physiol Cell Physiol. 2009 Aug;297(2):C389-96. doi: 10.1152/ajpcell.00206.2009.

11.

Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cells.

Kumerz M, Heiss EH, Schachner D, Atanasov AG, Dirsch VM.

Mol Nutr Food Res. 2011 Aug;55(8):1230-6. doi: 10.1002/mnfr.201100309.

12.

Slit2-N inhibits PDGF-induced migration in rat airway smooth muscle cells: WASP and Arp2/3 involved.

Ning Y, Sun Q, Dong Y, Xu W, Zhang W, Huang H, Li Q.

Toxicology. 2011 Apr 28;283(1):32-40. doi: 10.1016/j.tox.2011.01.026.

PMID:
21315131
13.

The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils.

Tole S, Mukovozov IM, Huang YW, Magalhaes MA, Yan M, Crow MR, Liu GY, Sun CX, Durocher Y, Glogauer M, Robinson LA.

J Leukoc Biol. 2009 Dec;86(6):1403-15. doi: 10.1189/jlb.0609391.

PMID:
19759280
14.

Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.

Kappert K, Sparwel J, Sandin A, Seiler A, Siebolts U, Leppänen O, Rosenkranz S, Ostman A.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2644-51.

15.

Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis.

Wang LJ, Zhao Y, Han B, Ma YG, Zhang J, Yang DM, Mao JW, Tang FT, Li WD, Yang Y, Wang R, Geng JG.

Cancer Sci. 2008 Mar;99(3):510-7. doi: 10.1111/j.1349-7006.2007.00721.x.

16.

Regulation of human vascular smooth muscle cell migration by beta-adrenergic receptors.

Johnson R, Webb JG, Newman WH, Wang Z.

Am Surg. 2006 Jan;72(1):51-4.

PMID:
16494183
17.

Rho-GDP dissociation inhibitor alpha downregulated by low shear stress promotes vascular smooth muscle cell migration and apoptosis: a proteomic analysis.

Qi YX, Qu MJ, Long DK, Liu B, Yao QP, Chien S, Jiang ZL.

Cardiovasc Res. 2008 Oct 1;80(1):114-22. doi: 10.1093/cvr/cvn158.

PMID:
18540023
18.

The cell motility modulator Slit2 is a potent inhibitor of platelet function.

Patel S, Huang YW, Reheman A, Pluthero FG, Chaturvedi S, Mukovozov IM, Tole S, Liu GY, Li L, Durocher Y, Ni H, Kahr WH, Robinson LA.

Circulation. 2012 Sep 11;126(11):1385-95. doi: 10.1161/CIRCULATIONAHA.112.105452.

19.

Protein disulfide isomerase is required for platelet-derived growth factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase expression, and RhoGTPase activation.

Pescatore LA, Bonatto D, Forti FL, Sadok A, Kovacic H, Laurindo FR.

J Biol Chem. 2012 Aug 24;287(35):29290-300. doi: 10.1074/jbc.M112.394551.

20.

Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function.

Liu Y, Dolence J, Ren J, Rao M, Sreejayan N.

J Cardiovasc Pharmacol. 2008 Nov;52(5):422-9. doi: 10.1097/FJC.0b013e31818aed93.

PMID:
19033821

Supplemental Content

Support Center